Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Muscle Invasive Bladder Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Affiliated Hospital of Chongqing Medica University, Chongqing, China

Study leads
  • Xin Gou, Professor

    Study Chair

    cymnk@163.com